Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
27
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Knobil Katharine | Director | 6 | $0 | $0 | 2025-11-17 |
| Eansor Norman David | Director | 12 | $250.0K | $0 | 2025-11-17 |
| ELMS STEVE | Director | 9 | $2.04M | $0 | 2025-11-17 |
| Corzo Kathryn Penkus | Director | 1 | $0 | $0 | 2025-10-31 |
| Vera Juan | President and CEO | 12 | $1000.0K | $0 | 2025-10-31 |
| NEA Partners 16, L.P. | 10% Owner | 2 | $11.77M | $0 | 2024-12-23 |
| Wilson John Robert | Director | 6 | $3.00M | $0 | 2023-06-06 |
| Szymanska Anna | Vice President, Quality | 5 | $0 | $0 | 2023-02-27 |
| Agopyan Nadia | VP, Regulatory Affairs | 6 | $0 | $0 | 2023-02-27 |
| Koneru Mythili | Chief Medical Officer | 5 | $0 | $0 | 2023-02-27 |
| Hoang Tsvetelina P | VP, Research and Development | 5 | $0 | $0 | 2023-02-27 |
| Loiacono Michael | Chief Financial Officer | 6 | $0 | $0 | 2023-02-27 |
| Laskow-Pooley David | Director | 3 | $0 | $0 | 2022-05-24 |
| Kim Anthony H. | Chief Financial Officer | 7 | $0 | $0 | 2022-03-24 |
| Hoang Peter L. | President and CEO | 10 | $296.2K | $0 | 2022-03-24 |
| Garrett Gerald | Vice President, Clinical Ops. | 4 | $0 | $0 | 2022-02-17 |
| Wasserman Frederick Gerald | Director | 3 | $24.1K | $0 | 2021-06-08 |
| Chang Carmen | 10% Owner | 1 | $10.00M | $0 | 2021-03-16 |
| Makhzoumi Mohamad | 10% Owner | 1 | $10.00M | $0 | 2021-03-16 |
| Behbahani Ali | 10% Owner | 1 | $10.00M | $0 | 2021-03-16 |
| Florence Anthony A. Jr. | 10% Owner | 1 | $10.00M | $0 | 2021-03-16 |
| Sonsini Peter W. | 10% Owner | 1 | $10.00M | $0 | 2021-03-16 |
| Walker Paul Edward | 10% Owner | 1 | $10.00M | $0 | 2021-03-16 |
| BASKETT FOREST | 10% Owner | 1 | $10.00M | $0 | 2021-03-16 |
| SANDELL SCOTT D | 10% Owner | 1 | $10.00M | $0 | 2021-03-16 |
| MAKOWER JOSHUA | 10% Owner | 1 | $10.00M | $0 | 2021-03-16 |
| DART KENNETH BRYAN | 10% Owner | 3 | $0 | $0 | 2020-06-16 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| ELMS STEVE | Director | A Award deriv | 2025-11-17 | 2025-11-19 | 137,330 | — | $0 | 137,330 | SEC↗ |
| ELMS STEVE | Director | A Award deriv | 2025-11-17 | 2025-11-19 | 84,411 | — | $0 | 84,411 | SEC↗ |
| Eansor Norman David | Director | A Award deriv | 2025-11-17 | 2025-11-19 | 137,330 | — | $0 | 137,330 | SEC↗ |
| Eansor Norman David | Director | A Award deriv | 2025-11-17 | 2025-11-19 | 84,411 | — | $0 | 84,411 | SEC↗ |
| Knobil Katharine | Director | A Award deriv | 2025-11-17 | 2025-11-19 | 84,411 | — | $0 | 84,411 | SEC↗ |
| Knobil Katharine | Director | A Award deriv | 2025-11-17 | 2025-11-19 | 137,330 | — | $0 | 137,330 | SEC↗ |
| Vera Juan | Chief Executive Officer | A Award deriv | 2025-10-31 | 2025-11-04 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Corzo Kathryn Penkus | Director | A Award deriv | 2025-10-31 | 2025-11-04 | 147,611 | — | $0 | 147,611 | SEC↗ |
| Vera Juan | President and CEO | A Award deriv | 2025-02-12 | 2025-02-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Eansor Norman David | Director | A Award deriv | 2025-02-12 | 2025-02-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Knobil Katharine | Director | A Award deriv | 2025-02-12 | 2025-02-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ELMS STEVE | Director | A Award deriv | 2025-02-12 | 2025-02-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NEA Partners 16, L.P. | 10% Owner | P Buy | 2024-12-23 | 2024-12-23 | 554,250 | $3.20 | $1.77M | 1,625,678 | SEC↗ |
| ELMS STEVE | Director | P Buy | 2024-12-23 | 2024-12-26 | 11,085 | $3.20 | $35.5K | 325,370 | SEC↗ |
| ELMS STEVE | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Wilson John Robert | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Knobil Katharine | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Eansor Norman David | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Vera Juan | President and CEO | A Award deriv | 2023-05-10 | 2023-05-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Agopyan Nadia | SVP, Regulatory Affairs | A Award deriv | 2023-02-27 | 2023-03-01 | 34,154 | — | $0 | 34,154 | SEC↗ |
| Szymanska Anna | Vice President, Quality | A Award deriv | 2023-02-27 | 2023-03-01 | 29,947 | — | $0 | 29,947 | SEC↗ |
| Vera Juan | Chief Scientific Officer & C | A Award deriv | 2023-02-27 | 2023-03-01 | 46,487 | — | $0 | 46,487 | SEC↗ |
| Loiacono Michael | Chief Accounting Officer | A Award deriv | 2023-02-27 | 2023-03-01 | 38,480 | — | $0 | 38,480 | SEC↗ |
| Koneru Mythili | Chief Medical Officer | A Award deriv | 2023-02-27 | 2023-03-01 | 51,918 | — | $0 | 51,918 | SEC↗ |
| Hoang Tsvetelina P | VP, Research and Development | A Award deriv | 2023-02-27 | 2023-03-01 | 33,159 | — | $0 | 33,159 | SEC↗ |
| Eansor Norman David | Director | A Award deriv | 2022-05-24 | 2022-05-26 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ELMS STEVE | Director | A Award deriv | 2022-05-24 | 2022-05-26 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Knobil Katharine | Director | A Award deriv | 2022-05-24 | 2022-05-26 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Laskow-Pooley David | Director | A Award deriv | 2022-05-24 | 2022-05-26 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Wilson John Robert | Director | A Award deriv | 2022-05-24 | 2022-05-26 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Kim Anthony H. | Chief Financial Officer | F Tax w/h | 2022-03-24 | 2022-03-28 | 36,076 | $0.48 | $17.3K | 114,436 | SEC↗ |
| Kim Anthony H. | Chief Financial Officer | A Award | 2022-03-24 | 2022-03-28 | 150,512 | — | $0 | 150,512 | SEC↗ |
| Vera Juan | Chief Scientific Officer & C | F Tax w/h | 2022-03-24 | 2022-03-28 | 33,465 | $0.48 | $16.1K | 2,671,845 | SEC↗ |
| Vera Juan | Chief Scientific Officer & C | A Award | 2022-03-24 | 2022-03-28 | 140,823 | — | $0 | 2,705,310 | SEC↗ |
| Hoang Peter L. | President and CEO | F Tax w/h | 2022-03-24 | 2022-03-28 | 48,376 | $0.48 | $23.2K | 483,286 | SEC↗ |
| Hoang Peter L. | President and CEO | A Award | 2022-03-24 | 2022-03-28 | 199,094 | — | $0 | 531,662 | SEC↗ |
| Agopyan Nadia | VP, Regulatory Affairs | A Award deriv | 2022-02-17 | 2022-02-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Garrett Gerald | Vice President, Clinical Ops | A Award deriv | 2022-02-17 | 2022-02-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Hoang Tsvetelina P | VP, Research and Development | A Award deriv | 2022-02-17 | 2022-02-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Kim Anthony H. | Chief Financial Officer | A Award deriv | 2022-02-17 | 2022-02-22 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Koneru Mythili | Chief Medical Officer | A Award deriv | 2022-02-17 | 2022-02-22 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Loiacono Michael | Chief Accounting Officer | A Award deriv | 2022-02-17 | 2022-02-22 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Szymanska Anna | Vice President, Quality | A Award deriv | 2022-02-17 | 2022-02-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Vera Juan | Chief Scientific Officer & C | A Award deriv | 2022-02-17 | 2022-02-22 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Hoang Peter L. | President and CEO | A Award deriv | 2022-02-17 | 2022-02-22 | 430,000 | — | $0 | 430,000 | SEC↗ |
| Knobil Katharine | Director | A Award deriv | 2021-12-08 | 2021-12-09 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Wilson John Robert | Director | A Award | 2021-06-08 | 2021-06-10 | 12,658 | — | $0 | 7,812,008 | SEC↗ |
| Eansor Norman David | Director | A Award | 2021-06-08 | 2021-06-10 | 12,658 | — | $0 | 36,940 | SEC↗ |
| ELMS STEVE | Director | A Award | 2021-06-08 | 2021-06-10 | 12,658 | — | $0 | 29,680 | SEC↗ |
| Laskow-Pooley David | Director | A Award | 2021-06-08 | 2021-06-10 | 12,658 | — | $0 | 55,223 | SEC↗ |
| Wasserman Frederick Gerald | Director | A Award | 2021-06-08 | 2021-06-10 | 12,658 | — | $0 | 65,223 | SEC↗ |
| Wasserman Frederick Gerald | Director | P Buy | 2021-05-18 | 2021-05-20 | 10,000 | $2.41 | $24.1K | 52,565 | SEC↗ |
| Eansor Norman David | Director | G Gift | 2021-03-25 | 2023-06-08 | 7,142 | — | $0 | 7,142 | SEC↗ |
| Eansor Norman David | Director | G Gift | 2021-03-25 | 2023-06-08 | 14,285 | — | $0 | 2,428 | SEC↗ |
| Eansor Norman David | Director | G Gift | 2021-03-25 | 2023-06-08 | 7,142 | — | $0 | 7,142 | SEC↗ |
| Eansor Norman David | Director | P Buy | 2021-03-16 | 2023-06-08 | 14,285 | $17.50 | $250.0K | 16,713 | SEC↗ |
| ELMS STEVE | Director | P Buy | 2021-03-16 | 2021-03-18 | 1,142,857 | $1.75 | $2.00M | 3,142,857 | SEC↗ |
| Hoang Peter L. | President and CEO | P Buy | 2021-03-16 | 2021-03-18 | 142,857 | $1.75 | $250.0K | 332,568 | SEC↗ |
| Vera Juan | Chief Development Officer | P Buy | 2021-03-16 | 2021-03-18 | 571,428 | $1.75 | $1000.0K | 2,564,487 | SEC↗ |
| Wilson John Robert | Director | P Buy | 2021-03-16 | 2021-03-18 | 1,714,285 | $1.75 | $3.00M | 7,799,350 | SEC↗ |
| NEA Partners 16, L.P. | 10% Owner | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| BASKETT FOREST | 10% Owner | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| Behbahani Ali | 10% Owner | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| Chang Carmen | 10% Owner | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| Makhzoumi Mohamad | 10% Owner | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| MAKOWER JOSHUA | 10% Owner | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| Sonsini Peter W. | 10% Owner | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| Walker Paul Edward | 10% Owner | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| Hoang Peter L. | President and CEO | A Award deriv | 2021-02-11 | 2021-02-12 | 430,000 | — | $0 | 430,000 | SEC↗ |
| Agopyan Nadia | VP, Regulatory Affairs | A Award deriv | 2021-02-10 | 2021-02-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Garrett Gerald | Vice President, Clinical Ops | A Award deriv | 2021-02-10 | 2021-02-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Hoang Tsvetelina P | VP, Research and Development | A Award deriv | 2021-02-10 | 2021-02-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Kim Anthony H. | Chief Financial Officer | A Award deriv | 2021-02-10 | 2021-02-12 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Koneru Mythili | Chief Medical Officer | A Award deriv | 2021-02-10 | 2021-02-12 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Loiacono Michael | Chief Accounting Officer | A Award deriv | 2021-02-10 | 2021-02-12 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Szymanska Anna | Vice President, Quality | A Award deriv | 2021-02-10 | 2021-02-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Vera Juan | Chief Development Officer | A Award deriv | 2021-02-10 | 2021-02-12 | 140,000 | — | $0 | 140,000 | SEC↗ |
| DART KENNETH BRYAN | 10% Owner | J Other deriv | 2020-06-16 | 2020-06-19 | 416,667 | — | $0 | 0 | SEC↗ |
| Agopyan Nadia | VP, Regulatory Affairs | A Award deriv | 2020-03-10 | 2020-03-12 | 7,300 | — | $0 | 7,300 | SEC↗ |
| Agopyan Nadia | VP, Regulatory Affairs | A Award deriv | 2020-03-10 | 2020-03-12 | 32,700 | — | $0 | 32,700 | SEC↗ |
| Garrett Gerald | Vice President, Clinical Ops | A Award deriv | 2020-03-10 | 2020-03-12 | 1,700 | — | $0 | 1,700 | SEC↗ |
| Garrett Gerald | Vice President, Clinical Ops | A Award deriv | 2020-03-10 | 2020-03-12 | 38,300 | — | $0 | 38,300 | SEC↗ |
| Hoang Tsvetelina P | VP, Research and Development | A Award deriv | 2020-03-10 | 2020-03-12 | 14,600 | — | $0 | 14,600 | SEC↗ |
| Hoang Tsvetelina P | VP, Research and Development | A Award deriv | 2020-03-10 | 2020-03-12 | 25,400 | — | $0 | 25,400 | SEC↗ |
| Kim Anthony H. | Chief Financial Officer | A Award deriv | 2020-03-10 | 2020-03-12 | 32,500 | — | $0 | 32,500 | SEC↗ |
| Kim Anthony H. | Chief Financial Officer | A Award deriv | 2020-03-10 | 2020-03-12 | 127,500 | — | $0 | 127,500 | SEC↗ |
| Koneru Mythili | Chief Medical Officer | A Award deriv | 2020-03-10 | 2020-03-12 | 116,100 | — | $0 | 116,100 | SEC↗ |
| Koneru Mythili | Chief Medical Officer | A Award deriv | 2020-03-10 | 2020-03-12 | 23,900 | — | $0 | 23,900 | SEC↗ |
| Loiacono Michael | Chief Accounting Officer | A Award deriv | 2020-03-10 | 2020-03-12 | 20,900 | — | $0 | 20,900 | SEC↗ |
| Loiacono Michael | Chief Accounting Officer | A Award deriv | 2020-03-10 | 2020-03-12 | 119,100 | — | $0 | 119,100 | SEC↗ |
| Szymanska Anna | Vice President, Quality | A Award deriv | 2020-03-10 | 2020-03-12 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Szymanska Anna | Vice President, Quality | A Award deriv | 2020-03-10 | 2020-03-12 | 32,500 | — | $0 | 32,500 | SEC↗ |
| Vera Juan | Chief Development Officer | A Award deriv | 2020-03-10 | 2020-03-12 | 26,600 | — | $0 | 26,600 | SEC↗ |
| Vera Juan | Chief Development Officer | A Award deriv | 2020-03-10 | 2020-03-12 | 113,400 | — | $0 | 113,400 | SEC↗ |
| Hoang Peter L. | President and CEO | A Award deriv | 2020-03-10 | 2020-03-12 | 388,800 | — | $0 | 388,800 | SEC↗ |
| Hoang Peter L. | President and CEO | A Award deriv | 2020-03-10 | 2020-03-12 | 41,200 | — | $0 | 41,200 | SEC↗ |
| DART KENNETH BRYAN | 10% Owner | X Exercise deriv | 2020-02-18 | 2020-02-20 | 416,667 | — | $0 | 0 | SEC↗ |
| DART KENNETH BRYAN | 10% Owner | X Exercise | 2020-02-18 | 2020-02-20 | 416,667 | $1.20 | $500.0K | 4,050,001 | SEC↗ |
| Agopyan Nadia | VP, Regulatory Affairs | A Award deriv | 2019-08-15 | 2019-08-19 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Hoang Peter L. | President and CEO | P Buy | 2019-08-14 | 2019-08-15 | 10,000 | $4.62 | $46.2K | 189,711 | SEC↗ |
| ELMS STEVE | Director | A Award deriv | 2019-08-06 | 2019-08-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Wasserman Frederick Gerald | Director | A Award | 2019-05-09 | 2019-05-13 | 7,260 | — | $0 | 25,543 | SEC↗ |
| Laskow-Pooley David | Director | A Award | 2019-05-09 | 2019-05-13 | 7,260 | — | $0 | 25,543 | SEC↗ |
| Wilson John Robert | Director | A Award | 2019-05-09 | 2019-05-13 | 7,260 | — | $0 | 6,068,043 | SEC↗ |
| Eansor Norman David | Director | A Award | 2019-05-09 | 2019-05-13 | 7,260 | — | $0 | 7,260 | SEC↗ |
| Kim Anthony H. | Chief Financial Officer | A Award deriv | 2018-11-27 | 2018-11-29 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Loiacono Michael | Chief Financial Officer | A Award deriv | 2018-10-19 | 2018-10-23 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Vera Juan | Director | A Award deriv | 2018-10-19 | 2018-10-23 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Hoang Peter L. | Chief Executive Officer | A Award deriv | 2018-10-19 | 2018-10-23 | 1,359,855 | — | $0 | 1,359,855 | SEC↗ |
| Hoang Peter L. | Chief Executive Officer | A Award deriv | 2018-10-19 | 2018-10-23 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Wilson John Robert | Director | A Award deriv | 2018-10-17 | 2018-10-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Eansor Norman David | Director | A Award deriv | 2018-10-17 | 2018-10-19 | 12,500 | — | $0 | 12,500 | SEC↗ |